Ramaekers JG

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 40, Maastricht, 6229 ER, The Netherlands. j.ramaekers@maastrichtuniversity.nl.

Ramaekers JG

Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy Volunteers

Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adults

Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Evaluating the evidence for repressed memory recovery in psychedelic contexts.

Brain-body integromics of the ayahuasca experience.

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

An international mega-analysis of psychedelic drug effects on brain circuit function.

Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.

Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin

Neurocomputational evidence of sustained Self-Other mergence after psychedelics

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.

Between enhancement and risk: A critical review of psychedelic microdosing.

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.

Less is more? Antidepressant effects of short-acting psychedelics.

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?

Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study.

The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin

A virtual clinical trial of psychedelics to treat patients with disorders of consciousness

Inter-individual variability in neural response to low doses of LSD.

Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.

Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.

Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.

The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience.

Shared functional connectome fingerprints following ritualistic ayahuasca intake.

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.

Cortical structural differences following repeated ayahuasca use hold molecular signatures.

Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness

Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.

Harnessing placebo: Lessons from psychedelic science.

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.

Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.

The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience

Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition

Ritualistic use of ayahuasca enhances a shared functional connectome identity with others

The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users.

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions.

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience.

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.

Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study.

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.

Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

Acute Effects of 2C-E in Humans: An Observational Study.

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.

MDMA-Induced Dissociative State not Mediated by the 5-HT<sub>2A</sub> Receptor.

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.